Eberhard Standl
Impact in
- Endocrinology, Diabetes and Metabolism top 0.05%
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
-
- Cardiovascular Function and Risk Factors
Papers in
-
- Diabetes Treatment and Management 90
- Diabetes Management and Research 64
- Diabetes, Cardiovascular Risks, and Lipoproteins 21
-
- Cardiovascular Function and Risk Factors 24
- Co-authors
- Oliver Schnell (67 shared papers)Lars Rydén (6 shared papers)Antonio Ceriello (21 shared papers)Darren K. McGuire (12 shared papers)Rury R. Holman (20 shared papers)Jennifer B. Green (12 shared papers)Eric David Peterson (10 shared papers)John B. Buse (11 shared papers)
- Journals
- Diabetes Care (23 papers)Cardiovascular Diabetology (22 papers)Diabetologia (20 papers)Diabetes (10 papers)Diabetes Research and Clinical Practice (9 papers)
- Partner nations
- GermanyItalyUnited Kingdom
In The Last Decade
Eberhard Standl
237 papers receiving 15.7k citations
Eberhard Standl's Hit Papers
Peers
Comparison fields: 5 of 162
- Endocrinology, Diabetes and Metabolism 8.8k
- Cardiology and Cardiovascular Medicine 2.9k
- Surgery 3.0k
- Transplantation 168
- Pharmacology 939
Countries citing papers authored by Eberhard Standl
This map shows the geographic impact of Eberhard Standl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eberhard Standl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eberhard Standl more than expected).
Fields of papers citing papers by Eberhard Standl
This network shows the impact of papers produced by Eberhard Standl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eberhard Standl. The network helps show where Eberhard Standl may publish in the future.
Co-authors
The 25 scholars most cited alongside Eberhard Standl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 252 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial Hit paper breakdown → | 2005 | 3391 |
| 2 | Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes Hit paper breakdown → | 2015 | 2080 |
| 3 | Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary Hit paper breakdown → | 2007 | 1313 |
| 4 | 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes Hit paper breakdown → | 2023 | 939 |
| 5 | Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications Hit paper breakdown → | 2019 | 689 |
| 6 | 2004 | 431 | |
| 7 | The global epidemics of diabetes in the 21st century: Current situation and perspectives Hit paper breakdown → | 2019 | 352 |
| 8 | 2007 | 319 | |
| 9 | 2015 | 267 | |
| 10 | 2017 | 254 | |
| 11 | 2007 | 247 | |
| 12 | Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials Hit paper breakdown → | 2023 | 209 |
| 13 | 2005 | 196 | |
| 14 | 2007 | 191 | |
| 15 | 2016 | 179 | |
| 16 | 1996 | 157 | |
| 17 | 2011 | 151 | |
| 18 | 1980 | 121 | |
| 19 | 2012 | 120 | |
| 20 | 2006 | 108 |
About Eberhard Standl
Eberhard Standl is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Physiology, Genetics and Surgery, having authored 252 papers that have together received 16.8k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (90 papers), Diabetes Management and Research (64 papers), Diabetes and associated disorders (34 papers), Metabolism, Diabetes, and Cancer (34 papers), Diet and metabolism studies (28 papers), Pancreatic function and diabetes (26 papers), Cardiovascular Function and Risk Factors (24 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (8.8k citations), Cardiology and Cardiovascular Medicine (2.9k citations), Surgery (3.0k citations), Transplantation (168 citations) and Pharmacology (939 citations). Eberhard Standl has collaborated with scholars based in Germany, Italy and United Kingdom. Frequent co-authors include Oliver Schnell, Lars Rydén, Antonio Ceriello, Darren K. McGuire, Rury R. Holman, Jennifer B. Green, Eric David Peterson, John B. Buse, Paul W. Armstrong and Mary Angelyn Bethel. Their work appears in journals such as Diabetes Care, Cardiovascular Diabetology, Diabetologia, Diabetes and Diabetes Research and Clinical Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.